Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Other Working Capital Changes (2024 - 2025)

Historic Other Working Capital Changes for Indivior Pharmaceuticals (INDV) over the last 2 years, with Q3 2025 value amounting to -$7.0 million.

  • Indivior Pharmaceuticals' Other Working Capital Changes fell 27500.0% to -$7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.0 million, marking a year-over-year change of. This contributed to the annual value of -$377.0 million for FY2024, which is 19019.14% down from last year.
  • Indivior Pharmaceuticals' Other Working Capital Changes amounted to -$7.0 million in Q3 2025, which was down 27500.0% from -$49.0 million recorded in Q2 2025.
  • Over the past 5 years, Indivior Pharmaceuticals' Other Working Capital Changes peaked at $18.0 million during Q1 2025, and registered a low of -$396.0 million during Q1 2024.